Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of Non-alcoholic Fatty Liver Disease Cohort and Development of Markers to Predict Histologic Progression of Liver Fibrosis

NCT02206841 is registered in ClinicalTrials.gov with Seoul National University Boramae Hospital as lead sponsor.

NCT NCT02206841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02206841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of Non-alcoholic Fatty Liver Disease Cohort and Development of Markers to Predict Histologic Progression of Liver Fibrosis
Lead sponsor
Seoul National University Boramae Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2014
Completion date
December 31, 2030
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis of liver